Gaurav H. Patel, MD, PhD

Monica Lypson MD MHPE is the Rolf H. Scholdager Professor of Medicine at Columbia University Irving Medical Center and the Vice Dean for Medical Education. She previously served as a professor, Vice-Chair of Medicine and Division Director of General Internal Medicine at The George Washington University School of Medical and Health Sciences and was President of the Society of General Internal Medicine from 2021-22. Her work focuses on innovations and improvements in health professions education and assessment, health equity, workforce diversity, faculty development, medical care delivery, and provider communication skills. Dr. Lypson's prior role in government included a position as the Director for Medical and Dental Education for the Veterans Health Administration, where she oversaw undergraduate and graduate medical education across the nation within the Department of Veteran Affairs. Dr. Lypson has held many national roles focused on health professions education, including with the Accreditation Council of Graduate Medical Education, the Association of American Medical Colleges, and the National Board of Medical Examiners. She is a board-certified general internist with significant leadership experience in clinical, educational, and administrative arenas. She is a clinician educator and has published over 100 peer-reviewed publications in top-tier medical education journals in the areas of resident assessment, communication skills, cultural competency education, workforce diversity and faculty development. Dr. Lypson graduated from Brown University and received her medical degree from Case Western Reserve University School of Medicine. She completed her graduate medical training at the Brigham and Women's Hospital in Internal Medicine - Primary Care, an affiliate of Harvard Medical School. Subsequently, she went on to complete a Robert Wood Johnson Clinical Scholars program at the University of Chicago and a master’s in Health Professions Education at the University of Illinois at Chicago. She is also a former Aspen Institute Health Innovators Fellow.

Daniel Diamond, OD, is Assistant Professor of Optometric Sciences (in Ophthalmology) at Columbia University Irving Medical Center. Dr. Diamond specializes in pediatrics, anterior segment disease, contact lens fitting, and primary and post-operative care. Dr. Diamond received his bachelor's degree in biology with a concentration in Molecular Biology at SUNY Binghamton. He then went on to complete his Doctorate in Optometry at the New England College of Optometry. He obtained his residency training in ocular disease at ENRM VA Hospital in Bedford, MA. Since joining the department, Dr. Diamond has received a fellowship from the American Academy of Optometry, published work on the vision and eye health of at-risk individuals in New York City, and lectured on the use of contact lenses in infants.

Brian Marr, MD heads the Ophthalmic Oncology Service at the Harkness Eye Institute. He has comprehensive experience in the diagnosis, treatment, and management of ocular tumors including intraocular tumor resection, laser, radiation, and chemotherapy procedures. He has helped devise thousands of complex treatments for tumors of the eye, eyelid, orbit, and conjunctiva for his adult, children, and infant patients. Currently, Dr. Marr is a collaborator on a Columbia University clinical trial for a first-of-its-kind, new class of drug treatment for uveal melanoma. Dr. Marr is a board-certified ophthalmologist whose work has centered around ophthalmic oncology since 2000. One of the very few ocular oncologists trained in all aspects of eye cancer, Dr. Marr's clinical experience in treating these diseases is among the most extensive in the United States. His interest and experience in ophthalmic oncology began during an eight-year tenure in the Ocular Oncology Service at the Wills Eye Hospital in Philadelphia. There, he gained extensive experience treating intraocular tumors, and tumors of the eyelid, orbit, and conjunctiva in children and adults. It was there that Dr. Marr developed and improved many surgical procedures used to cure cancers of the eye, successfully treated thousands of patients, and helped their families though their battle with eye cancer. Next, Dr. Marr moved on to Memorial Sloan Kettering Cancer Center, where he remain for nine years, starting in 2008. Dr. Marr has some of the greatest experience with intra-arterial chemotherapy for treating retinoblastoma in the country, if not the world, as well as all other forms of retinoblastoma treatment. He has been a key member of many multidisciplinary surgical teams, treating advanced skull base tumors and complex facial skin lesions. He has developed a strong belief and treatment philosophy that the best research be used to help his patients, rather than his best patients be used to help his research. The field of ophthalmic oncology encompasses many rare conditions and his experience helps his patients get the best care and results as quickly as possible. Dr. Marr lectures and consults across the US and abroad, and has authored numerous research articles in the field of ocular oncology. He is the principal investigator in a first-in-class drug study for treating primary uveal melanoma, in an international, multi-center trial. He also volunteers his medical expertise in underserviced parts of the world, such as Nigeria and Indonesia, and has helped train physicians in more than 20 countries. Dr. Marr’s efforts as a contributor to ongoing education in ocular oncology have been recognized by the American Academy of Ophthalmology, where he now serves as chief editor of the Academy’s Oncology and Pathology’s One network.